[TOVX] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
31-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -19.83%
YoY- 73.76%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,990 -3,528 -2,326 -3,058 -11,078 -12,358 -3,838 -4.07%
Tax -26 -16 -2,674 -5,303 264 4,151 0 -
NP -2,964 -3,512 -2,316 -2,846 -10,845 -12,358 -3,838 -4.21%
Tax Rate - - - - - - - -
Total Cost 2,964 3,512 2,316 2,846 10,845 12,358 3,838 -4.21%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -1.73 -2.24 -6.30 -8.48 -41.79 -59.52 -23.03 -35.01%
EPS Diluted -1.73 -2.24 -6.30 -8.48 -41.79 -59.52 -23.03 -35.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.